217 related articles for article (PubMed ID: 26577839)
1. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
[TBL] [Abstract][Full Text] [Related]
2. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Cancer Causes Control; 2023 May; 34(5):431-447. PubMed ID: 36790512
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.
Cheng TY; Shankar J; Zirpoli G; Roberts MR; Hong CC; Bandera EV; Ambrosone CB; Yao S
Cancer Causes Control; 2016 Aug; 27(8):965-76. PubMed ID: 27314662
[TBL] [Abstract][Full Text] [Related]
4. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Gong Z; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Breast Cancer Res Treat; 2023 May; 199(1):137-146. PubMed ID: 36882608
[TBL] [Abstract][Full Text] [Related]
5. Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.
Wang S; Huo D; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Zheng Y
Carcinogenesis; 2017 Aug; 38(8):789-796. PubMed ID: 28582508
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
[TBL] [Abstract][Full Text] [Related]
7. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.
Hong CC; Sucheston-Campbell LE; Liu S; Hu Q; Yao S; Lunetta KL; Haddad SA; Ruiz-Narváez EA; Bensen JT; Cheng TD; Bandera EV; Rosenberg LA; Haiman CA; Lee K; Evans SS; Abrams SI; Repasky EA; Olshan AF; Palmer JR; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):321-330. PubMed ID: 29339359
[No Abstract] [Full Text] [Related]
9. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry.
Wang S; Huo D; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Zheng Y
Mol Carcinog; 2018 Oct; 57(10):1311-1318. PubMed ID: 29873413
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
12. Hormone-related pathways and risk of breast cancer subtypes in African American women.
Haddad SA; Lunetta KL; Ruiz-Narváez EA; Bensen JT; Hong CC; Sucheston-Campbell LE; Yao S; Bandera EV; Rosenberg L; Haiman CA; Troester MA; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2015 Nov; 154(1):145-54. PubMed ID: 26458823
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S; Haddad SA; Hu Q; Liu S; Lunetta KL; Ruiz-Narvaez EA; Hong CC; Zhu Q; Sucheston-Campbell L; Cheng TY; Bensen JT; Johnson CS; Trump DL; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Int J Cancer; 2016 May; 138(9):2118-26. PubMed ID: 26650177
[TBL] [Abstract][Full Text] [Related]
14. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
[TBL] [Abstract][Full Text] [Related]
15. mTOR pathway candidate genes and energy intake interaction on breast cancer risk in Black women from the Women's Circle of Health Study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Eur J Nutr; 2023 Sep; 62(6):2593-2604. PubMed ID: 37209192
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
[TBL] [Abstract][Full Text] [Related]
18. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
[TBL] [Abstract][Full Text] [Related]
19. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
20. Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women.
Cheng TD; Omilian AR; Yao S; Zhang W; Datta S; Bshara W; Ondracek RP; Davis W; Liu S; Hong CC; Bandera EV; Khoury T; Ambrosone CB
Breast Cancer Res; 2021 Jul; 23(1):77. PubMed ID: 34330319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
